[Confirmed NRTI remains an important therapy option. Didanosine effective despite multiple resistance to NRTIs].
D016049:Didanosine / Q000009:adverse effects / Q000627:therapeutic use*; D024921:Drug Resistance, Multiple, Viral / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D019562:Viral Load / Q000145:classification
D018894:Reverse Transcriptase Inhibitors; D016049:Didanosine
Bewährter NRTI bleibt wichtige Therapieoption. Didanosin trotz mehrerer Resistenzen gegen NRTIs wirksam.